Senescent cells that accumulate in our bodies are a major cause of health problems and enable cancer development as we age. Researchers at Cleara Biotech discovered the mechanism how senescent cells escape the natural elimination process.
Location: Netherlands
Total raised: $2.5M
Investors 2
| Date | Name | Website |
| - | Curie Capi... | curiecapit... |
| - | Apollo Ven... | apollo.vc |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 29.09.2022 | Seed | $2.5M | - |
Mentions in press and media 4
| Date | Title | Description | Source |
| 30.12.2022 | Dutch-based biotech and life sciences startups that raised f... | The Netherlands is swiftly rising to the top as a hub for healthcare and life sciences innovation. M... | siliconcan... |
| 29.09.2022 | Dutch-based Cleara raises €2.58M to develop therapies agains... | Utrecht-based Cleara, a company on a mission to target cellular senescence to extend human healthspa... | siliconcan... |
| 28.09.2022 | Cleara Biotech Raises $2.5M in Seed Financing | Cleara Biotech B.V., an Utrecht, The Netherlands-based preclinical-stage biotechnology company spun ... | finsmes.co... |
| - | Cleara Biotech | “Cleara Biotech is a biopharmaceutical R&D company dedicated to discovery and development of the... | fastfounde... |